发明公开
EP2436700A1 Shortened purification process for the production of capsular streptococcus pneumoniae polysaccharides
有权
VerkürztesReinigungsverfahrenfürdie Herstellung von Capsularstreptococcus pneumoniae-Polysacchariden
- 专利标题: Shortened purification process for the production of capsular streptococcus pneumoniae polysaccharides
- 专利标题(中): VerkürztesReinigungsverfahrenfürdie Herstellung von Capsularstreptococcus pneumoniae-Polysacchariden
-
申请号: EP11194173.8申请日: 2008-03-20
-
公开(公告)号: EP2436700A1公开(公告)日: 2012-04-04
- 发明人: Yuan, Yonghui , Ruppen, Mark , Sun, Wei-Qiang , Chu, Ling , Simpson, John , Patch, James , Fink Charbonneau, Pamela , Moran, Justin K.
- 申请人: Wyeth LLC
- 申请人地址: Five Giralda Farms Madison, NJ 07940 US
- 专利权人: Wyeth LLC
- 当前专利权人: Wyeth LLC
- 当前专利权人地址: Five Giralda Farms Madison, NJ 07940 US
- 代理机构: Ricol, David Gerard
- 优先权: US89661607P 20070323
- 主分类号: C08B37/00
- IPC分类号: C08B37/00 ; A61K47/48
摘要:
A shortened process for producing a solution containing substantially purified capsular polysaccharides from a cellular Streptococcus pneumoniae lysate broth is described. Ultrafiltering and diafiltering a clarified S. pneumoniae lysate followed by pH adjustment to less than 4.5, preferably about 3.5, precipitated at least 98% of the protein in the solution without seriously affecting polysaccharide yield. Furthermore, following ultrafiltration and diafiltration and acidification to a pH of less than 4.5, filtration using activated carbon precipitated at least 90% of remaining protein without seriously affecting polysaccharide yield. Exemplary, non-limiting S. pneumoniae serotypes that can be purified using the shortened process of the invention are 1, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F. In one embodiment, the Streptococcus pneumoniae cells are lysed using deoxycholate sodium (DOC), while in another embodiment the lytic agent is a non-animal derived lytic agent such as N-lauryl sarcosine sodium (NLS).
公开/授权文献
信息查询